INTRODUCTION
In the recent years, essential oils have gained massive acceptance due to their applications in number of pharmaceutical and food products because of their potential in inhibiting the growth and propagations of a wide range of microorganisms such as bacteria, fungi and virus 1 3 . Clove essential oil CEO is an essential oil isolated from flower buds of Syzygium aromaticum L. Family: Myrtaceae , advocated in the treatment of various diseases 2 4 . Many pharmacological bioactivities including anti-inflammatory, analgesic, antibacterial, antifungal, anti-allergic, anti-carcinogenic and anti-mutagenic activities have been reported for CEO 1, 5 10 . Several phytochemicals have been identified in CEO such as eugenol, acetyleugenol, isoeugenol, methyleugenol, carvacrol, thymol, cinnamaldehyde, eugenyl acetate, β-caryophyllene, 2-heptanone, methyl salicylate, α-humulene, gallic acid, ellagic acid and oleanolic acid etc 2 4 .
Eugenol 88.58 is the major constituent of CEO which sulated nanoemulsions have not been investigated in literature. Therefore, the aim of this article was to develop, characterize and evaluate nanoemulsion formulations of CEO in order to enhance its antibacterial effects. The antibacterial effects of CEO nanoemulsions were also compared with pure oil and antibiotic amikacin positive control against five bacterial strains namely Bacillus subtilis, Staphyloccocus aureus, Proteus vulgaris, Pseudomonas aeruginosa and Klebseilla pneumonia. All these bacteria are known to cause several infectious diseases such as endovascular infection Staphyloccocus aureus , food poisoning Bacillus subtilis , urinary tract infections Proteus vulgaris , pulmonary & urinary tract infections Pseudomonas aeruginosa and Pneumonia Klebseilla pneumonia 28 31 . Most of these bacterial are resistant to various antibiotics, hence there is an urgent need of an alternative therapy for the treatment of the infections caused by these bacteria. 
EXPERIMENTAL

Construction of pseudo-ternary phase diagrams
In present study, Triacetin, Tween-80 and Labrasol were used as oil phase, surfactant and cosurfactant, respectively for the development of CEO nanoemulsions. However, deionized water used as aqueous phase. For the construction of pseudo-ternary phase diagrams, Surfactant Tween-80 and cosurfactant Labrasol were mixed in mass ratios of 1:0, 1:2, 1:1, 2:1 and 3:1. Triacetin oil phase and a particular mass ratio of surfactant to cosurfactant S mix were mixed at mass ratios of 1:9 to 9:1. Pseudo-ternary phase diagrams were developed by aqueous phase titration method by titrating the mixture of oil phase and specific S mix slowly with deionized water 13 . The physical state of prepared nanoemulsions was marked on a pseudo-ternary phase diagram with one axis representing the aqueous phase, second oil phase Triacetin and third representing the specific mass ratio of surfactant Tween-80 to cosurfactant Labrasol .
Preparation of CEO nanoemulsions
From the pseudo-ternary phase diagram, nanoemulsion zones were pointed out and different formulations with different compositions from this location were chosen for the preparation of CEO nanoemulsions. Considering pseudo-ternary phase diagrams, maximum nanoemulsion zones were represented by 1:1 mass ratio of Tween-80 to Labrasol in varying proportions. Therefore, different formulations were selected from 1:1 mass ratio of S mix . Almost entire range of nanoemulsion occurrence in the phase diagram was taken into account and varied oil compositions with minimum surfactant concentration were selected. 1 w/w of CEO was mixed with required amount of Triacetin oil phase, varied from 8 to 24 w/w . The fixed amount of S mix 30 w/w was added to CEO-Triactin mixture and water was added with drop-wise manner till an apparent and clear solution was obtained. The composition of CEO nanoemulsions is listed in Table 1. 2.4 Thermodynamic stability and self-nanoemulsi cation tests Thermodynamic stability tests on developed CEO nanoemulsions were performed to eliminate unstable formulations and to select stable one. CEO nanoemulsions were However, the objective of self-nanoemulsification test was to investigate any precipitation or phase separation upon dilution with water. To perform this test, 1 ml of each CEO nanoemulsion F1-F5 was diluted with 500 ml of deionized water. The efficiency of each nanoemulsion was investigated visually using the following grading systems 32, 33 :
Grade A: Rapid forming clear/transparent nanoemulsion emulsify within 1 minute Grade B: Rapid forming bluish white nanoemulsion emulsify within 2 minute Grade C: Milky emulsions more than 2 minutes to emulsify Grade D: Dull, grayish milky emulsions more than 3 minutes to emulsify Grade E: Formulations with oil globules at the surface 2.5 Measurement of droplet size, polydispersity and zeta potential The mean droplet size, polydispersity index PI and zeta potential ZP of CEO nanoemulsions F1-F5 were measured using Malvern Particle Size Analyzer Malvern Instruments Ltd., Holtsville, NY at 25 . In order to perform these measurements, each nanoemulsion was diluted 200 times with deionized water, sonicated for 10 min and filtered via 0.45 μm membrane filters. The scattering angle for the measurement was fixed at 90 . The scattering signals were detected by a high-sensitivity avalanche photodiode detector 34 .
Measurement of viscosity and transmittance
The viscosity of CEO nanoemulsions F1-F5 was measured using Brookfield Viscometer Brookfield Engineering Laboratories, Middleboro, MA at 25 1 without any dilution. However the percentage of transmittance T of CEO nanoemulsions was measured spectrophotometrically at 550 nm as reported in literature 32, 33 .
Transmission electron microscopy
Transmission electron microscopy TEM operating at 200 KV Tecnai TF20, Hillsboro, OR was performed to investigate surface morphology and droplet size distribution of optimized formulation F1. In order to carry out TEM experiments, optimized CEO nanoemulsion F1 was diluted 200 times with water and a drop was deposited on the carbon-coated copper grid. The excess amount of liquid was blotted and negative staining was performed with 2 phosphotungstic acid for 10 sec and blotted dry for 30 sec.
The grid was then observed under light microscopy operating at 200 KV 13 .
Antibacterial studies
Based on lowest droplet size, lowest PI, lowest viscosity, optimal ZP, highest T and after all lowest concentration of Triacetin, CEO nanoemulsion F1 was optimized and selected for antibacterial studies as a test formulation. Agarcup diffusion method was used to evaluate antibacterial effects 3 in order to compare antibacterial effects of optimized test formulation F1 with standard amikacin which was used as positive control in present study. These studies were carried out against five bacterial species which are known to pathogenic for human and animals namely Bacillus subtilis, Staphyloccocus aureus, Proteus vulgaris, Pseudomonas aeruginosa and Klebseilla pneumonia 3, 28 .
All these bacterial strains were activated in nutrient agar at 37 for 24 h. The selection of these bacterial strains was based on their pharmacological and clinical relevance 2, 3, 28 .
All bacterial species were cultivated on Mueller-Hinton agar Oxoid, England . On solidification, 5 mm holes were made with sterile borer and 0.25 ml of test strains were inoculated in the media separately. The solutions 100 μl of test formulation and amikacin positive control were introduced into each well and plates were incubated at 37 for 24 h. Pure clove oil was diluted with sterile normal saline solution 0.9 w/v with the help of Tween-80 at final concentration of 1 w/w was also applied to evaluate its antibacterial effects. Sterile normal saline solution was used as negative control. Optimized formulation F1 without CEO blank formulation was also applied to investigate formulation effects on antibacterial activity. The inhibition zones mm around the wells were measured for all sample matrices investigated. The inhibition zones of blank formulation were subtracted from the inhibition zones of CEO nanoemulsions F1. The minimum inhibitory concentration MIC of F1, amikacin positive control and CEO were also measured by the broth two-fold macro dilution method in Mueller-Hinton agar medium against all bacterial strains 3 .
Statistical analysis
The significance of difference in physicochemical parameters and antibacterial activities was evaluated by applying the one-way analysis of variance ANOVA test using a statistical software package Graphpad Prism version 4, San Diego, CA . Differences between related parameters were considered statistically significant at p 0.05.
RESULTS
Pseudo-ternary phase diagrams for the development of CEO nanoemulsions were constructed separately for each S mix ratio in order to optimize effective formulations Fig. 1 . From the phase diagrams, it was observed that S mix 1:0 had very low nanoemulsion zones Fig. 1A . The highest amount of Triacetin oil phase that was solubilized by 1:0 ratio was 9 w/w by utilizing higher percentage of S mix 82 w/w . However, in case of S mix 1:2 Fig. 1B , when cosurfactant Labrasol was used along with the surfactant Tween-80 , the nanoemulsion zones were found to be increased rapidly as compared to 1:0 ratio. The highest amount of Triacetin that was solubilized by this ratio was found to be 16 w/w by incorporating 64 w/w of S mix . On the other hand, when S mix ratio of 1:1 Fig. 1C was studied, the nanoemulsion zones were found to be increased significantly as compared to 1:0 and 1:2 ratios. The highest amount of Triacetin that was solubilized by 1:1 ratio was 
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found to be 28 w/w by incorporating 41 w/w of S mix , itself showed the dominance of cosurfactant Labrasol along with surfactant Tween-80 in nanosizing of nanoemulsions. The increased nanoemulsion zones in 1:1 mass ratio of S mix were probably due to the synergistic effects of Tween-80 and Labrasol. When S mix ratio of 2:1 was studied Fig. 1D , the nanoemulsion zones were started to decreased as compared to 1:1 ratio. The highest amount of Triacetin that was solubilized by this ratio was found to be 22 w/w by incorporation of 52 w/w of S mix . When S mix ratio of 3:1 was studied Fig. 1E , the nanoemulsion zones were found to be decreased further as compared to 2:1 as well as 1:1 ratios. The highest amount of Triacetin that was solubilized by this ratio was found to be 17 w/w by incorporation of 39 w/w of S mix . For the development and optimization of robust nanoemulsions, the selected formulations were subjected to thermodynamic stability tests in terms of centrifugation, heating & cooling cycles and freeze-pump-thaw cycles. Thermodynamically stable nanoemulsions F1-F5 were further investigated for self-nanoemulsification test using A-E grading systems. It was observed that formulations F1, F2 and F3 passed this test with grade A while the formulations F4 and F5 passed this test with grade B.
The results of droplet size distribution, PI and ZP of CEO nanoemulsions are summarized in Table 2 . The mean droplet size of nanoemulsions F1-F5 was observed in the range of 29.1-136.9 nm. The droplet size of formulations F1 and F2 was observed to be very close with each other Table 2 . The viscosity of formulations was also found to be enhanced by increasing the concentration of Triacetin in formulations. The T of CEO nanoemulsions F1-F5 was observed in the range of 92.3-99.4 Table 2 . The T of formulations was also found to be reduced by increasing the concentration of Triacetin in formulations. The highest T was observed in formulation F1 99.4 0.1 . However, the lowest one was observed in formulation F5 92.3 0. 4 . The results of T studies indicated transparent behavior of all formulations.
The surface morphology and shape of droplets was studied using TEM. Photomicrograph of optimized nanoemulsion F1 was taken and interpreted for surface morphology and droplet size distribution. The size of all droplets was observed less than 35 nm as shown in Fig. 2 .
The results of antibacterial effects of test, positive control and pure CEO in terms of zone of inhibitions mm and MICs are listed in Table 3 .
DISCUSSION
With regard to pseudo-ternary phase diagrams, highest nanoemulsion zones were exposed by S mix ratio of 1:1 Fig.  1C . Therefore, different nanoemulsions with different compositions were precisely selected from Fig. 1 based on evidence based performance of thermodynamic stability studies. Almost the entire region of nanoemulsion occurrence in the phase diagrams was covered and different oil compositions 8, 12, 16 and 20 w/w with fixed surfactant # mean droplet diameter (Δdm), *polydispersity index (p ¡ ), viscosity mean (η ), %T (% transmittance), zeta potential (ZP), standard deviation (SD) concentration 30 w/w were precisely selected. 1 w/w of CEO was directly loaded on selected formulations. The composition of these nanoemulsions is listed in Table 1 .
The objective of these tests was to eliminate metastable and unstable formulations. Only those formulations, which were observed to be stable at all stress conditions of thermodynamic stability tests were selected for self-nanoemulsification test. Self-nanoemulsification tests were performed to investigate the phase separation or drug precipitation upon dilution with water. Largest droplet size was observed in formulation F5 136.9 11.2 nm due to the presence of highest concentration of Triacetin 24 w/ w . However, the droplet size of formulation F1 was found to be lowest 29. 4 and lowest concentration of Triacetin 8 w/w , CEO nanoemulsion F1 was selected as a test formulation to investigate its antibacterial effects. The standard amikacin and normal saline were selected as positive and negative control, respectively. Test formulation F1 showed good inhibition zones against all bacterial strains investigated. It was observed that the inhibition zone mm of CEO nanoemulsion F1 was larger than that of pure oil group against all bacterial strains. However, the inhibition zones of F1 were comparable with that of positive control amikacin against all bacterial strains. The antibacterial effects of F1 were superior than positive control against Staphyloccocus aureus, Proteus vulgaris and Pseudomonas aeruginosa Table 3 . The inhibition effects of pure oil group were very low against all bacterial strains as compared with F1 and positive control. On the other hand, nanoemulsion formulation without CEO blank formulation showed negligible zone of inhibition against all bacterial strains. The MICs of F1 were found to be lower 0.075-0.085 w/w against Bacillus subtilis, Staphyloccocus aureus and Proteus vulgaris as compared to Pseudomonas aeruginosa MIC 0.300 w/w and Klebseilla pneumoniae MIC 0.250 w/w . However, the MICs of pure oil group were very low as compared to F1 against all bacterial strains investigated. The MICs of positive control were observed in the range of 2-16 μg/ml against all bacterial strains which were similar to the reported MICs of amikacin against these bacterial strains 28 31 . Finally, it was observed that there was a significant difference in inhibition activity of F1 and pure oil group p 0.05 . Results of ANOVA indicated that developed nanoemulsion F1 showed significant zone of inhibition against all bacterial strains as compared to pure oil group p 0.05 .
CONCLUSIONS
In the present study, nanoemulsion formulations of CEO were developed and evaluated for antibacterial effects. CEO nanoemulsions were prepared by low energy emulsification method and characterized for droplet size, PI, viscosity, ZP and transmittance. Based on lowest droplet size 29.1 nm , lowest PI 0.026 , lowest viscosity 34.6 cp , optimal ZP -31.4 mV , highest T 99. 4 and lowest concentration of Triacetin 8 w/w , CEO nanoemulsion F1 containing 1 w/w of CEO, 8 w/w of Triacetin, 15 w/w of Tween-80, 15 w/w of Labrasol and 61 w/w of water was optimized as an effective formulation of CEO and subjected to antibacterial studies. The antibacterial effects of F1 were found to be superior over pure oil and highly comparable with standard amikacin against all bacterial strains investigated. These results indicated the potential of nanoemulsions for enhancing the therapeutic efficacy of natural active ingredients such as CEO.
